ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

about

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

Item

http://www.wikidata.org/entity/Q50956599

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@en

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@nl

type

Item

label

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@en

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@nl

prefLabel

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@en

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@nl

P1476

ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.

@en

P2093

David E Schwartz

http://www.w3.org/2001/XMLSchema#string

Randal O Dull

http://www.w3.org/2001/XMLSchema#string

Sergei M Danilov

http://www.w3.org/2001/XMLSchema#string

Stan I Tovsky

http://www.w3.org/2001/XMLSchema#string

P2860

Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA

Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.

Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE

Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain

An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding

Antihypertensive pharmacogenetics: getting the right drug into the right patient.

Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.

Angiotensin-converting enzyme inhibitors.

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Conformational changes of blood ACE in chronic uremia.

P304

374-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248416686188

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28587581

http://www.w3.org/2001/XMLSchema#string